| scholarly article | Q13442814 |
| P356 | DOI | 10.1016/S0306-4522(98)00219-X |
| P698 | PubMed publication ID | 10336117 |
| P50 | author | Etienne C. Hirsch | Q72610464 |
| Stéphane Hunot | Q55965563 | ||
| P2093 | author name string | R Raisman-Vozari | |
| Q Yan | |||
| Y Agid | |||
| M G Murer | |||
| B Faucheux | |||
| J Villares | |||
| F Boissiere | |||
| P2860 | cites work | Regulated release and polarized localization of brain-derived neurotrophic factor in hippocampal neurons | Q28566523 |
| Targeted disruption of the BDNF gene perturbs brain and sensory neuron development but not motor neuron development. | Q30488256 | ||
| Histochemically distinct compartments in the striatum of human, monkeys, and cat demonstrated by acetylthiocholinesterase staining | Q33861374 | ||
| A structural superfamily of growth factors containing a cystine knot motif | Q34061958 | ||
| Selective loss of cholinergic neurons in the ventral striatum of patients with Alzheimer disease | Q34317571 | ||
| Inhibition of GABAA synaptic responses by brain-derived neurotrophic factor (BDNF) in rat hippocampus | Q34421008 | ||
| Characterization of glial trkB receptors: differential response to injury in the central and peripheral nervous systems | Q36329542 | ||
| Nuclear translocation of NF-kappaB is increased in dopaminergic neurons of patients with parkinson disease | Q36659955 | ||
| Anatomy, pigmentation, ventral and dorsal subpopulations of the substantia nigra, and differential cell death in Parkinson's disease | Q36947501 | ||
| Virus-mediated gene transfer into hippocampal CA1 region restores long-term potentiation in brain-derived neurotrophic factor mutant mice | Q37242848 | ||
| Promotion of central cholinergic and dopaminergic neuron differentiation by brain-derived neurotrophic factor but not neurotrophin 3. | Q37390129 | ||
| Brain-derived neurotrophic factor: subcellular compartmentalization and interneuronal transfer as visualized with anti-peptide antibodies | Q37614778 | ||
| Expanded distribution of mRNA for nerve growth factor, brain-derived neurotrophic factor, and neurotrophin 3 in the rat brain after colchicine treatment | Q37625508 | ||
| The nerve growth factor 35 years later | Q39667849 | ||
| Neurotrophins and neuronal plasticity | Q40418979 | ||
| Neurotrophic factors and synaptic plasticity | Q40423304 | ||
| The p75 neurotrophin receptor | Q40590902 | ||
| Brain-derived neurotrophic factor administration protects basal forebrain cholinergic but not nigral dopaminergic neurons from degenerative changes after axotomy in the adult rat brain | Q41100334 | ||
| Ex vivo gene transfer of brain-derived neurotrophic factor to the intact rat forebrain: neurotrophic effects on cholinergic neurons. | Q41207167 | ||
| Mice lacking brain-derived neurotrophic factor develop with sensory deficits | Q41481309 | ||
| Expression of catalytic trkB gene in the striatum and the basal forebrain of patients with Alzheimer's disease: an in situ hybridization study | Q42437412 | ||
| Neuronal deficits, not involving motor neurons, in mice lacking BDNF and/or NT4 | Q60074946 | ||
| BDNF and NT-3, but not NGF, prevent axotomy-induced death of rat corticospinal neurons in vivo | Q71383325 | ||
| TRK and p75 neurotrophin receptor systems in the developing human brain | Q71410632 | ||
| Efficacy of brain-derived neurotrophic factor and neurotrophin-3 on neurochemical and behavioral deficits associated with partial nigrostriatal dopamine lesions | Q71638153 | ||
| Neurotrophic factors and their receptors | Q71880802 | ||
| BDNF-activated signal transduction in rat cortical glial cells | Q71884022 | ||
| BDNF attenuates the effects of intrastriatal injection of 6-hydroxydopamine | Q72030743 | ||
| Highly restricted origin of prefrontal cortical inputs to striosomes in the macaque monkey | Q72037974 | ||
| The biological responses of axotomized adult motoneurons to brain-derived neurotrophic factor | Q72182827 | ||
| The neurotrophins BDNF, NT-3 and NT-4/5 promote survival and morphological and biochemical differentiation of striatal neurons in vitro | Q72254050 | ||
| Brain-derived neurotrophic factor is a survival factor for cultured rat cerebellar granule neurons and protects them against glutamate-induced neurotoxicity | Q72664326 | ||
| Decreased TrkA gene expression in cholinergic neurons of the striatum and basal forebrain of patients with Alzheimer's disease | Q42439576 | ||
| Nuclear translocation of NF-kappaB in cholinergic neurons of patients with Alzheimer's disease | Q42447369 | ||
| Brain-derived neurotrophic factor and neurotrophin-4/5 modify neurotransmitter-related gene expression in the 6-hydroxydopamine-lesioned rat striatum | Q42480727 | ||
| Localization of nerve growth factor receptors in the normal human brain and in Alzheimer's disease | Q42493367 | ||
| Brain-derived neurotrophic factor enhances striatal neuropeptide expression in both the intact and the dopamine-depleted rat striatum. | Q42495179 | ||
| Brain-derived neurotrophic factor (BDNF) prevents the degeneration of medial septal cholinergic neurons following fimbria transection | Q42497039 | ||
| BDNF mRNA is decreased in the hippocampus of individuals with Alzheimer's disease | Q43727698 | ||
| Brain-derived neurotrophic factor prevents the death of motoneurons in newborn rats after nerve section | Q44602903 | ||
| MPTP produces a pattern of nigrostriatal degeneration which coincides with the mosaic organization of the caudate nucleus | Q45744968 | ||
| Immunohistochemical visualization of brain-derived neurotrophic factor in the rat brain | Q46063500 | ||
| Distribution of brain-derived neurotrophic factor (BDNF) protein and mRNA in the normal adult rat CNS: evidence for anterograde axonal transport. | Q46109672 | ||
| Brain-derived neurotrophic factor rescues spinal motor neurons from axotomy-induced cell death | Q46535566 | ||
| Brain-derived neurotrophic factor increases survival and differentiated functions of rat septal cholinergic neurons in culture | Q46613635 | ||
| Differential regulation of brain-derived neurotrophic factor and type II calcium/calmodulin-dependent protein kinase messenger RNA expression in Alzheimer's disease | Q46642796 | ||
| Induction of noncatalytic TrkB neurotrophin receptors during axonal sprouting in the adult hippocampus | Q46743236 | ||
| Induction of basic Fibroblast Growth Factor in Alzheimerʼs disease pathology | Q46894345 | ||
| trkB messenger RNA expression in normal human brain and in the substantia nigra of parkinsonian patients: an in situ hybridization study | Q47734647 | ||
| Distribution of manganese-dependent superoxide dismutase in the human brain | Q48096226 | ||
| Fibers from the basolateral nucleus of the amygdala selectively innervate striosomes in the caudate nucleus of the cat. | Q48099100 | ||
| NT-3 and BDNF protect CNS neurons against metabolic/excitotoxic insults | Q48155678 | ||
| Requirement for BDNF in activity-dependent survival of cortical neurons | Q48156100 | ||
| Co-expression of mRNA for neurotrophic factors in human neurons and glial cells in culture | Q48195209 | ||
| Subdivisions of the dopamine-containing A8-A9-A10 complex identified by their differential mesostriatal innervation of striosomes and extrastriosomal matrix | Q48196559 | ||
| Localization of trkB mRNA in postnatal brain development | Q48237185 | ||
| Expression of members of the trk family in the developing postnatal rat brain | Q48319176 | ||
| Dimeric structure and conformational stability of brain-derived neurotrophic factor and neurotrophin-3. | Q48480955 | ||
| Brain-derived neurotrophic factor antisense oligonucleotide impairs memory retention and inhibits long-term potentiation in rats | Q48534416 | ||
| Brain-derived neurotrophic factor is reduced in Alzheimer's disease | Q48591280 | ||
| Brain-derived neurotrophic factor regulates maturation of the DARPP-32 phenotype in striatal medium spiny neurons: studies in vivo and in vitro | Q48678036 | ||
| Detection of brain-derived neurotrophic factor-like activity in fibroblasts and Schwann cells: inhibition by antibodies to NGF. | Q48680798 | ||
| TrkB signaling is required for postnatal survival of CNS neurons and protects hippocampal and motor neurons from axotomy-induced cell death. | Q48706935 | ||
| Transient and persistent expression of NT-3/HDNF mRNA in the rat brain during postnatal development | Q48710208 | ||
| Expression of brain-derived neurotrophic factor protein in the adult rat central nervous system | Q48720818 | ||
| Immunochemical analysis of dopamine transporter protein in Parkinson's disease | Q48742316 | ||
| BDNF is a neurotrophic factor for dopaminergic neurons of the substantia nigra | Q48767968 | ||
| Regional specificity of alterations in NGF, BDNF and NT-3 levels in Alzheimer's disease. | Q48858246 | ||
| NT-3, BDNF, and NGF in the developing rat nervous system: Parallel as well as reciprocal patterns of expression | Q48894918 | ||
| Immunohistochemical localization of brain-derived neurotrophic factor in adult rat brain | Q48906109 | ||
| Brain-derived neurotrophic factor promotes the survival and sprouting of serotonergic axons in rat brain. | Q50755884 | ||
| Recombinant BDNF rescues deficits in basal synaptic transmission and hippocampal LTP in BDNF knockout mice. | Q52201421 | ||
| Brain microglia/macrophages express neurotrophins that selectively regulate microglial proliferation and function. | Q52201985 | ||
| Cellular and substrate adhesion molecules (integrins) and their ligands in cerebral amyloid plaques in Alzheimer's disease. | Q53199812 | ||
| Immunoreactive epidermal growth factor receptors in neuritic plaques from patients with Alzheimer's disease. | Q53303541 | ||
| Distribution of neuronal growth-promoting factors and cytoskeletal proteins in altered neurites in Alzheimer's disease and non-demented elderly | Q53311603 | ||
| Ubiquitin immunoelectron microscopy of dystrophic neurites in cerebellar senile plaques of Alzheimer's disease | Q57306430 | ||
| Sensory but not motor neuron deficits in mice lacking NT4 and BDNF | Q59064394 | ||
| Molecular cloning and expression of brain-derived neurotrophic factor | Q59068124 | ||
| Regulation of synaptic responses to high-frequency stimulation and LTP by neurotrophins in the hippocampus | Q59085769 | ||
| P433 | issue | 4 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | Alzheimer's disease | Q11081 |
| immunohistochemistry | Q899285 | ||
| P304 | page(s) | 1015-1032 | |
| P577 | publication date | 1999-01-01 | |
| P1433 | published in | Neuroscience | Q15708571 |
| P1476 | title | An immunohistochemical study of the distribution of brain-derived neurotrophic factor in the adult human brain, with particular reference to Alzheimer's disease | |
| P478 | volume | 88 |
| Q34370099 | 7,8-dihydroxyflavone prevents synaptic loss and memory deficits in a mouse model of Alzheimer's disease |
| Q48308896 | A transgenic mouse model engineered to investigate human brain-derived neurotrophic factor in vivo |
| Q36824374 | Actions of brain-derived neurotrophic factor in slices from rats with spontaneous seizures and mossy fiber sprouting in the dentate gyrus. |
| Q36164551 | Altered balance of proteolytic isoforms of pro-brain-derived neurotrophic factor in autism |
| Q36060174 | BDNF Expression in Larval and Adult Zebrafish Brain: Distribution and Cell Identification |
| Q37061555 | BDNF and the diseased nervous system: a delicate balance between adaptive and pathological processes of gene regulation. |
| Q58710855 | BDNF inhibits neurodegenerative disease-associated asparaginyl endopeptidase activity via phosphorylation by AKT |
| Q89690206 | Born to Protect: Leveraging BDNF Against Cognitive Deficit in Alzheimer's Disease |
| Q38263685 | Brain-Derived Neurotrophic Factor in Alzheimer's Disease: Risk, Mechanisms, and Therapy |
| Q35911108 | Brain-derived neurotrophic factor as a drug target for CNS disorders |
| Q43708048 | Brain-derived neurotrophic factor enhances fast excitatory synaptic transmission in human epileptic dentate gyrus |
| Q34445162 | Brain-derived neurotrophic factor exerts neuroprotective actions against amyloid β-induced apoptosis in neuroblastoma cells |
| Q34017880 | Brain-derived neurotrophic factor in neurodegenerative diseases |
| Q34065279 | Brain-derived neurotrophic factor in the control human brain, and in Alzheimer's disease and Parkinson's disease |
| Q37579433 | Brain-derived neurotrophic factor levels in late-life depression and comorbid mild cognitive impairment: a longitudinal study. |
| Q39360293 | Brain-derived neurotrophic factor: mRNA expression and protein distribution in the brain of the teleost Nothobranchius furzeri. |
| Q55183055 | Cognitive Decline, Dementia, Alzheimer’s Disease and Presbycusis: Examination of the Possible Molecular Mechanism. |
| Q38789148 | Consequences of brain-derived neurotrophic factor withdrawal in CNS neurons and implications in disease |
| Q37947984 | Convergent pathogenic pathways in Alzheimer's and Huntington's diseases: shared targets for drug development. |
| Q38112245 | DNA methylation of the BDNF gene and its relevance to psychiatric disorders |
| Q35999021 | Decreased peripheral brain-derived neurotrophic factor levels in Alzheimer's disease: a meta-analysis study (N=7277). |
| Q91960810 | Deficiency in BDNF/TrkB Neurotrophic Activity Stimulates δ-Secretase by Upregulating C/EBPβ in Alzheimer's Disease |
| Q90024959 | Delta-secretase-cleaved Tau antagonizes TrkB neurotrophic signalings, mediating Alzheimer's disease pathologies |
| Q44913965 | Distribution of granulocyte-monocyte colony-stimulating factor and its receptor α-subunit in the adult human brain with specific reference to Alzheimer's disease |
| Q44888340 | Distribution of the hematopoietic growth factor G-CSF and its receptor in the adult human brain with specific reference to Alzheimer's disease |
| Q48288303 | Effects of Ginsenoside Rg1 on Learning and Memory in a Reward-directed Instrumental Conditioning Task in Chronic Restraint Stressed Rats |
| Q60949615 | Effects of a Cognitive Training With and Without Additional Physical Activity in Healthy Older Adults: A Follow-Up 1 Year After a Randomized Controlled Trial |
| Q47397177 | Elevated glial brain-derived neurotrophic factor in Parkinson's diseased nigra |
| Q43576677 | Expression and estrogen regulation of brain-derived neurotrophic factor gene and protein in the forebrain of female prairie voles |
| Q42451246 | Expression of BDNF mRNA in substantia nigra is dependent on target integrity and independent of neuronal activation |
| Q88978887 | Genetic Risk for Age-Related Cognitive Impairment Does Not Predict Cognitive Performance in Middle Age |
| Q48405135 | Hemodialysis decreases serum brain-derived neurotrophic factor concentration in humans |
| Q34098184 | Histopathology of the prefrontal cortex in major depression: what does it tell us about dysfunctional monoaminergic circuits? |
| Q48450749 | Immunohistochemical distribution of NGF, BDNF, NT-3, and NT-4 in adult rhesus monkey brains |
| Q40848213 | Immunohistochemical localization of glial cell line-derived neurotrophic factor in the human central nervous system |
| Q48105544 | Immunolocalization of pro- and mature-brain derived neurotrophic factor (BDNF) and receptor TrkB in the human brainstem and hippocampus |
| Q74424004 | Increased hippocampal BDNF immunoreactivity in subjects treated with antidepressant medication |
| Q33199294 | Induction of brain-derived neurotrophic factor in plaque-associated glial cells of aged APP23 transgenic mice. |
| Q48051942 | Inhibition of DNA Methylation in the Developing Rat Brain Disrupts Sexually Dimorphic Neurobehavioral Phenotypes in Adulthood |
| Q21131072 | Involvement of BDNF in age-dependent alterations in the hippocampus |
| Q35929042 | Lack of an association of BDNF Val66Met polymorphism and plasma BDNF with hippocampal volume and memory |
| Q35879259 | Left hippocampus-amygdala complex macro- and microstructural variation is associated with BDNF plasma levels in healthy elderly individuals |
| Q24562763 | Metabolic dysfunction in Alzheimer's disease and related neurodegenerative disorders |
| Q33778336 | Minimal peroxide exposure of neuronal cells induces multifaceted adaptive responses |
| Q34735544 | Molecular mechanisms of environmental enrichment: impairments in Akt/GSK3β, neurotrophin-3 and CREB signaling |
| Q37541846 | Molecular mechanisms underlying synergistic effects of SSRI-antipsychotic augmentation in treatment of negative symptoms in schizophrenia |
| Q36532418 | Neurobiological markers of exercise-related brain plasticity in older adults |
| Q64768197 | Neurotrophic factors in Alzheimer's and Parkinson's disease brain |
| Q22242329 | Neurotrophic factors in Alzheimer’s disease: role of axonal transport |
| Q37629100 | Neurotrophin signalling: novel insights into mechanisms and pathophysiology |
| Q22252335 | New insights into brain BDNF function in normal aging and Alzheimer disease |
| Q52137276 | Ontogeny of brain-derived neurotrophic factor gene expression in the forebrain of prairie and montane voles. |
| Q42210014 | PGC-1α or FNDC5 Is Involved in Modulating the Effects of Aβ1-42 Oligomers on Suppressing the Expression of BDNF, a Beneficial Factor for Inhibiting Neuronal Apoptosis, Aβ Deposition and Cognitive Decline of APP/PS1 Tg Mice |
| Q92826639 | Perineuronal Nets and Their Role in Synaptic Homeostasis |
| Q58698362 | Post-stroke BDNF Concentration Changes Following Physical Exercise: A Systematic Review |
| Q33924323 | Postmortem studies in mood disorders indicate altered numbers of neurons and glial cells |
| Q48627137 | Reduced brain-derived neurotrophic factor (BDNF) mRNA expression and presence of BDNF-immunoreactive granules in the spinocerebellar ataxia type 6 (SCA6) cerebellum |
| Q48395249 | Regulation of Neurotrophic Factors During Pathogenic Tau-Aggregation: A Detailed Protocol for Double-Labeling mRNA by In Situ Hybridization and Protein Epitopes by Immunohistochemistry |
| Q45360347 | Sendai virus vector-mediated brain-derived neurotrophic factor expression ameliorates memory deficits and synaptic degeneration in a transgenic mouse model of Alzheimer's disease |
| Q41811172 | Serum brain-derived neurotrophic factor levels in different neurological diseases. |
| Q48381635 | Sodium Channel Voltage-Gated Beta 2 Plays a Vital Role in Brain Aging Associated with Synaptic Plasticity and Expression of COX5A and FGF-2. |
| Q42938870 | The Effects of Antecedent Exercise on Motor Function Recovery and Brain-derived Neurotrophic Factor Expression after Focal Cerebral Ischemia in Rats |
| Q52726758 | The Efficacy and Underlying Mechanism of Moxibustion in Preventing Cognitive Impairment: A Systematic Review of Animal Studies. |
| Q34181430 | The aging hippocampus: interactions between exercise, depression, and BDNF |
| Q53376525 | The brain-derived neurotrophic factor gene as a possible susceptibility candidate for Alzheimer's disease in a chinese population. |
| Q36325596 | The expanding role of BDNF: a therapeutic target for Alzheimer's disease? |
| Q36980971 | The impact of Bdnf gene deficiency to the memory impairment and brain pathology of APPswe/PS1dE9 mouse model of Alzheimer's disease |
| Q44458631 | The neurite-stimulating activity of components of the salivary gland secretion of the medicinal leech in cultures of sensory neurons |
| Q39275474 | The use of deceased controls in epidemiological research: A systematic review |
| Q98386132 | TrkB receptor cleavage by delta-secretase abolishes its phosphorylation of APP, aggravating Alzheimer's disease pathologies |
| Q35184502 | Tyrosine kinase B protein expression is reduced in the cerebellum of patients with bipolar disorder |
| Q43423408 | Val66Met polymorphism and BDNF levels in Alzheimer's disease patients in North Indian population |
| Q37228087 | Variation in brain-derived neurotrophic factor (BDNF) gene is associated with symptoms of depression |
Search more.